[stock_market_widget type=”leaderboard” template=”color-background” color=”blue” assets=”GOSS” api=”yf”]

Gossamer Bio, Inc.

Description: Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. It has license agreement with Pulmokine, Inc. and Aerpio Pharmaceuticals, Inc. The company was formerly known as FSG, Bio, Inc. and changed its name to Gossamer Bio, Inc. in 2017.
Industry: Biotechnology
Founded Year : 2015
Headquarter : San Diego, CA, USA
Phone: 858-684-1300

[stock_market_widget type=”leaderboard” template=”color-background” color=”blue” assets=”ALEC” api=”yf”]

Alector, Inc.

Description: Alector, Inc., a clinical stage biotechnology company, developing humanized recombinant monoclonal antibody for the treatment of Alzheimer’s disease.
Industry: Biotechnology
Founded Year : 2013
Headquarter : South San Francisco, CA, USA
Phone: 415-231-5660

[stock_market_widget type=”leaderboard” template=”color-background” color=”blue” assets=”VIE” api=”yf”]

Viela Bio, Inc.

Description: Viela Bio, Inc., a clinical-stage biotechnology company, engages in the research and development of treatments for severe inflammation and autoimmune diseases in the United States. The company is developing inebilizumab, a humanized monoclonal antibody for neuromyelitis optica spectrum disorder; kidney transplant desensitization; myasthenia gravis; and IgG4-related diseases. The company has a strategic collaboration with Mitsubishi Tanabe Pharma Corporation to develop and commercialize inebilizumab for autoimmune diseases in Japan and Other Asia Regions.
Industry: Biotechnology
Founded Year : 2017
Headquarter : Gaithersburg, MA, USA
Phone: 240-558-0038

[stock_market_widget type=”leaderboard” template=”color-background” color=”blue” assets=”EDIT” api=”yf”]

Editas Medicine, Inc.

Description: Editas Medicine, Inc. operates as a clinical stage genome editing company. It develops a proprietary genome editing platform based on CRISPR technology to target genetically addressable diseases and therapeutic areas. The company was formerly known as Gengine, Inc. and changed its name to Editas Medicine, Inc. in November 2013.
Industry: Biotechnology
Founded Year : 2013
Headquarter : Cambridge, MA, USA
Phone: 617-401-9000

[stock_market_widget type=”leaderboard” template=”color-background” color=”red” assets=”1801.HK” api=”yf”]

Innovent Biologics

Description: .
Industry: Biotechnology
Founded Year : 2011
HeadquarterPeople’s Republic of China
Website: http://innoventbio.com/


Pages: 1 2 3 4 5 6 7

Recommended Posts

No comment yet, add your voice below!

Add a Comment

Your email address will not be published. Required fields are marked *